Skip to main content
. 2014 Aug 25;9(8):e106105. doi: 10.1371/journal.pone.0106105

Table 2. Overall survivals of each of the four MMR/BRAF phenotypes by Kaplan Meier actuarial analysis.

MMR/BRAF phenotype 5-year survival Mean survival
MMRp/BRAFV600E 52.6% 7.12 years (95%CI = 5.87–8.37)
MMRd/BRAFwt 64.2% 8.36 years (95%CI = 6.16–10.56)
MMRd/BRAFV600E 64.1% 8.08 years (96%CI = 7.04–9.40)
MMRp/BRAFwt 60.1% 8.06 years (95%CI = 7.62–8.50)